These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 29796500

  • 1. Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore.
    Gawne P, Man F, Fonslet J, Radia R, Bordoloi J, Cleveland M, Jimenez-Royo P, Gabizon A, Blower PJ, Long N, de Rosales RTM.
    Dalton Trans; 2018 Jul 17; 47(28):9283-9293. PubMed ID: 29796500
    [Abstract] [Full Text] [Related]

  • 2. A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3.
    Man F, Khan AA, Carrascal-Miniño A, Blower PJ, T M de Rosales R.
    Nucl Med Biol; 2020 Jul 17; 90-91():31-40. PubMed ID: 32979725
    [Abstract] [Full Text] [Related]

  • 3. Positron Emission Tomography-Magnetic Resonance Imaging Pharmacokinetics, In Vivo Biodistribution, and Whole-Body Elimination of Mn-PyC3A.
    Zhou IY, Ramsay IA, Ay I, Pantazopoulos P, Rotile NJ, Wong A, Caravan P, Gale EM.
    Invest Radiol; 2021 Apr 01; 56(4):261-270. PubMed ID: 33136686
    [Abstract] [Full Text] [Related]

  • 4. PET Imaging of Liposomal Glucocorticoids using 89Zr-oxine: Theranostic Applications in Inflammatory Arthritis.
    Gawne PJ, Clarke F, Turjeman K, Cope AP, Long NJ, Barenholz Y, Terry SYA, de Rosales RTM.
    Theranostics; 2020 Apr 01; 10(9):3867-3879. PubMed ID: 32226525
    [Abstract] [Full Text] [Related]

  • 5. Radiolabeled liposome imaging determines an indication for liposomal anticancer agent in ovarian cancer mouse xenograft models.
    Ito K, Hamamichi S, Asano M, Hori Y, Matsui J, Iwata M, Funahashi Y, Umeda IO, Fujii H.
    Cancer Sci; 2016 Jan 01; 107(1):60-7. PubMed ID: 26509883
    [Abstract] [Full Text] [Related]

  • 6. Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.
    Edmonds S, Volpe A, Shmeeda H, Parente-Pereira AC, Radia R, Baguña-Torres J, Szanda I, Severin GW, Livieratos L, Blower PJ, Maher J, Fruhwirth GO, Gabizon A, T M de Rosales R.
    ACS Nano; 2016 Nov 22; 10(11):10294-10307. PubMed ID: 27781436
    [Abstract] [Full Text] [Related]

  • 7. Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo Pharmacokinetics.
    Børresen B, Henriksen JR, Clergeaud G, Jørgensen JS, Melander F, Elema DR, Szebeni J, Engelholm SA, Kristensen AT, Kjær A, Andresen TL, Hansen AE.
    ACS Nano; 2018 Nov 27; 12(11):11386-11398. PubMed ID: 30372038
    [Abstract] [Full Text] [Related]

  • 8. Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications.
    Friberger I, Jussing E, Han J, Goos JACM, Siikanen J, Kaipe H, Lambert M, Harris RA, Samén E, Carlsten M, Holmin S, Tran TA.
    Mol Imaging Biol; 2021 Dec 27; 23(6):952-962. PubMed ID: 34231103
    [Abstract] [Full Text] [Related]

  • 9. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.
    Alibolandi M, Abnous K, Mohammadi M, Hadizadeh F, Sadeghi F, Taghavi S, Jaafari MR, Ramezani M.
    J Control Release; 2017 Oct 28; 264():228-236. PubMed ID: 28844758
    [Abstract] [Full Text] [Related]

  • 10. A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.
    Zhao Y, Alakhova DY, Kim JO, Bronich TK, Kabanov AV.
    J Control Release; 2013 May 28; 168(1):61-9. PubMed ID: 23474033
    [Abstract] [Full Text] [Related]

  • 11. Comparison of three different methods for radiolabelling human activated T lymphocytes.
    Botti C, Negri DR, Seregni E, Ramakrishna V, Arienti F, Maffioli L, Lombardo C, Bogni A, Pascali C, Crippa F, Massaron S, Remonti F, Nerini-Molteni S, Canevari S, Bombardieri E.
    Eur J Nucl Med; 1997 May 28; 24(5):497-504. PubMed ID: 9142729
    [Abstract] [Full Text] [Related]

  • 12. Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.
    Gabizon A, Tzemach D, Mak L, Bronstein M, Horowitz AT.
    J Drug Target; 2002 Nov 28; 10(7):539-48. PubMed ID: 12683721
    [Abstract] [Full Text] [Related]

  • 13. Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx® (doxorubicin HCl liposome injection) in syngeneic fibrosarcoma-bearing BALB/c mice and Sprague-Dawley rats.
    Burade V, Bhowmick S, Maiti K, Zalawadia R, Jain D, Rajamannar T.
    Cancer Chemother Pharmacol; 2017 May 28; 79(5):899-913. PubMed ID: 28349166
    [Abstract] [Full Text] [Related]

  • 14. Biodistribution and PET Imaging of pharmacokinetics of manganese in mice using Manganese-52.
    Wooten AL, Aweda TA, Lewis BC, Gross RB, Lapi SE.
    PLoS One; 2017 May 28; 12(3):e0174351. PubMed ID: 28306727
    [Abstract] [Full Text] [Related]

  • 15. Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging.
    Seynhaeve ALB, Dicheva BM, Hoving S, Koning GA, Ten Hagen TLM.
    J Control Release; 2013 Nov 28; 172(1):330-340. PubMed ID: 24012486
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo characterizations of PEGylated liposomal doxorubicin.
    Jiang W, Lionberger R, Yu LX.
    Bioanalysis; 2011 Feb 28; 3(3):333-44. PubMed ID: 21320053
    [Abstract] [Full Text] [Related]

  • 17. Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells.
    Polyak A, Bankstahl JP, Besecke KFW, Hozsa C, Triebert W, Pannem RR, Manstein F, Borcholte T, Furch M, Zweigerdt R, Gieseler RK, Bengel FM, Ross TL.
    Pharmaceutics; 2021 Jul 18; 13(7):. PubMed ID: 34371788
    [Abstract] [Full Text] [Related]

  • 18. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies.
    Xiao P, Zhao J, Huang Y, Jin R, Tang Z, Wang P, Song X, Zhu H, Yang Z, Yu N.
    Pharm Nanotechnol; 2020 Jul 18; 8(5):391-398. PubMed ID: 32787769
    [Abstract] [Full Text] [Related]

  • 19. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L, Badiee A, Mosaffa F, Jaafari MR.
    J Control Release; 2015 Dec 28; 220(Pt A):275-286. PubMed ID: 26518722
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution of 89Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography imaging in Sprague-Dawley rats.
    Wang S, Wang Y, Xu B, Qin T, Lv Y, Yan H, Shao Y, Fang Y, Zheng S, Qiu Y.
    Nucl Med Commun; 2022 Jul 01; 43(7):834-846. PubMed ID: 35438673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.